Cancer fibroblast growth factor

Powers, C.J., McLeskey, S.W., and Wellstein, A. 2000. Fibroblast growth factors, their receptors and signalling. Endocrine Related Cancer 1(3), 165-197. 

Galy, B., A. Maret, A. C. Prats, and H. Prats. 1999. Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms. Cancer Res 59(1) 165-71. 

Powers, C. et. al. (2000). Fibroblast growth factors, their receptors and signalling. Endocr. Rel. Cancer 7(3), 165-197. Souchelnytskyi, S. (2002). Transforming growth factor-/) signalling and its role in cancer. Exp. Oncol. 24(1), 3-12. Zhu, X., Komiya, A., Chirino, S. et al. (1991). Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251, 90. 

Dinney, C.P, D.R. Bielenberg, P. Perrotte, R. Reich, B.Y. Eve, C.D. Bucana, and I.J. Fidler, Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res, 1998. 58(4) 808-14. 

R. D. Alvarez, G. P. Siegal, J. T. Douglas, and D. T. Curiel, Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer, Clin. Cancer Res. 4 2455 (1998). 

Dirix L, Vermeulen P, Pawinski A, Prove A, Benoy I, De Pooter C, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997 76 238-243. 

C5. Carstens, R. P., Eaton, J. V., Krigman, H. R., Walther, P. J., and Garcia-Bianco, M. A., Alternative splicing of fibroblast growth factor receptor 2 (FGF-R-2) in human prostate cancer. Oncogene 15, 3059-3065 (1997). 

F4. Feng, S., Wang, F., Matsubara, A., Kan, M., and McKeehan, W. L., Fibroblast growth factor receptor-2 limits and receptor-1 accelerates tumorigenicity of prostate epithelial cells. Cancer... 

Kurebayashi, J., McLeskey, S. W., Johnson, M. D., Lippman, M. E., Dickson, R. B. and Kern, F. G. (1993). Quantitative demonstration of spontaneous metastais by MCF7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res. 53, 2178-2187. 

Glucose deprivation has been shown to cause activation of Lyn kinase, c-Jun W-terminal kinase 1 and to increase the expression of basic fibroblast growth factor and c-Myc in adri-amycin-resistant human breast cancer cells. Thus, glucose oxidation may be linked to cellular oxidative stress as evidenced from increase in the steady state of oxidized glutathione and intracellular peroxides [85]. A unique glucose-dependent apoptotic pathway is induced by the cellular oncogen c-Myc in transformed fibroblasts [86]. 

N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, and J.S. Pagano, Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2, Cancer Res 62, 6337-6344 (2002). 

Morrison, R. S., Yamaguchi, F., Bruner, J. M., Tang, M., McKeehan, W., and Berger, M. S., Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme, Cancer Res., 54, 2794, 1994. 

---